SOPHiA GENETICS and Myriad Genetics are collaborating to develop a decentralized prostate cancer companion diagnostic, aiming to enable local labs to assess DNA repair deficiencies using the PrGIS biomarker in clinical trials.
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
Agilent Technologies will acquire digital pathology software provider Proscia in a deal valued at up to $270 million, expanding Agilent’s presence in digital diagnostics and enterprise pathology software.
Clinisys has integrated document intelligence into its Laboratory Solution platform, enabling labs to convert unstructured documents into searchable, governed data for improved workflow efficiency and reduced manual entry.
Biodesix presented data at CHEST 2026 from over 2,000 patients in the CLARIFY study, highlighting how Nodify Lung blood-based testing integrates with PET imaging to improve follow-up adherence for pulmonary nodules.
